http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0503002-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_785ac2b35073f5a6d251678e6fb31b6f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-20022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-708
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-70
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-025
filingDate 1990-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57d6c24e45eb397ef4b937591f919bae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13d74d16acffe2ccef26221bdf886586
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7617bbaf865bf2ee985693705b36dd77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bd94ed5c75d5405b9d2488bae6f399c
publicationDate 1992-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0503002-A1
titleOfInvention Antisense oligonucleotide inhibition of papillomavirus
abstract Oligonucleotides and oligonucleotide analogues which may have a non-coding interaction with the messenger RNA of the papilloma virus. Such oligonucleotides or oligonucleotide analogs can be used for diagnosis and therapy as well as for research purposes. According to preferred embodiments, the oligonucleotide or oligonucleotide analog is hybridizable with messenger RNA from a papilloma virus, can inhibit RNA function, and is therefore useful in the therapy of infections caused by a such papilloma virus. According to a preferred embodiment, parts of the papilloma virus are targeted for a non-coding attack. It is therefore possible to obtain the preferable oligonucleotides, that is to say those which hybridize with the messenger RNAs E2, E1, E7, or E6-7.
priorityDate 1989-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8806634-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0301968-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8905357-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0373352-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1891767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128328033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226520094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128417629
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8259
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD1MEJ0
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1891767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3009847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ03181
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID61971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5959
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101938
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10566
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID337052
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10566
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID61971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127610602
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35396
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406329
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID337052

Total number of triples: 61.